Company / Assets per Share
Dyne Therapeutics, Inc. Assets per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.76
FY2024
5-year range
$2.69 / $24.54
FY2020-FY2024
Trend
+151.6%
vs FY2023
Sector context
#130 of 212
Health Care
What the data says
At $6.76, Dyne Therapeutics, Inc.'s assets per share ranks #130 of 212 in the Health Care sector. Assets per Share returned to growth in FY2024 after 3 years of decline, reaching $6.76.
Based on SEC 10-K filings.
6.76 in FY2024 with a 5-year CAGR of +0.1%.
Improved from $5.51 to $6.76 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -6.9%
- 5-Year CAGR
- +0.1%
- 10-Year CAGR
- -
Sector benchmark
#130 of 212 in Health CareTop 61% of 212This company $6.76 Sector average $294.36
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2024, assets per share increased 151.6% year-over-year.
- Ranks #130 out of 212 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.76 | +151.6% |
| FY2023 | $2.69 | -51.2% |
| FY2022 | $5.51 | -34.2% |
| FY2021 | $8.36 | -65.9% |
| FY2020 | $24.54 | +264.8% |
| FY2019 | $6.73 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026